A study funded by Pfizer-BioNTech showed the efficacy of its Covid-19 vaccine – while still high – declined by 13 percentage points over six months after the second dose, suggesting there could be a need for booster shots in the future. More than 46,000 people in the United States, Turkey, Brazil, Argentina, South Africa and Germany were monitored for the...